Rocky Mountain High Brands Enters Greater Los Angeles Market


Rocky Mountain High Brands Enters Greater Los Angeles Market

 DALLAS, June 28, 2016 (GLOBE NEWSWIRE) —
Rocky Mountain High Brands, Inc. (OTC PINK:RMHB) announced today that the Company has entered into an agreement with ENM Sales & Services (ENM) to represent its product line and to introduce and actively market its hemp-infused beverages in the Los Angeles metropolitan area and the Southern Nevada region.
ENM Sales and Service boasts an impressive list of large independent and high profile major chain stores such as Walgreens, CVS, Food4Less, Los Altos Ranch Market and many more. ENM has become the sales and marketing choice for powerhouse brands such as Hostess, McCormick, Dolores Chili Brick, and Mojave due to the company’s emphasis in merchandising traditional and multi-cultural markets such as the region’s large Hispanic population.
Joey Duran of ENM Sales and Services, stated, “ENM has a solid reputation of effectively marketing product lines through our fully owned Promotional Support Division.  In-store demonstrations and promotions are designed to increase brand awareness.  ENM product demonstrators encourage consumers to sample our brands as we explain the key benefits and value of the products. Our product demonstrators are sales-minded and results-oriented and, customers are always encouraged to Try it and Buy it.
Visit ENM Sales and Service online at: http://www.enmsales.com/home
Michael R. Welch, President and Chief Executive Officer of Rocky Mountain High Brands, remarked, “The Latino population, which represents over 40% of Los Angeles, needs to be addressed in a complete marketing strategy for the southwest region. Our reformulated Mango energy drink has been tested and we believe it will become our best-selling drink, with a particular appeal to this demographic. Our decision to develop a relationship with ENM Sales and Services is based on their expertise of expanding beyond traditional demographics. ENM delivers a complete merchandising program that includes a boots on the ground approach that will present Rocky Mountain High Brands in a direct face-to-face sales presentation.”
Jose Alvarez of ENM, added, “Latino cultures are impacting grocery stores so much that they have redefined American cuisine. The Latino Food and Beverage market in the U.S. reached almost $8.2 billion in 2012 and is expected to reach $10.7 billion in 2017. Growth is up 31% from the present market levels among our client list of larger food chains in Southern California such as Anaheim-based Northgate Gonzalez with thirty stores and Sylmar-based Vallarta Supermarkets with twenty-five stores. ENM plans on showcasing Rocky Mountain High Brands in supermarkets that are currently experiencing the highest dynamic growth.”
About ENM Sales & Services:
With over 35 years of experience, ENM Sales & Services has supplied the greater Los Angeles and Southern Nevada area with a diverse product line of food and beverages to fast growing independent and major chain stores. The company’s unique marketing strategy includes an in-house promotional support division that promotes sales of products through in-store demonstrations and promotions.
Visit ENM on Twitter: https://twitter.com/enmsales
About Rocky Mountain High Brands:
 
ROCKY MOUNTAIN HIGH BRANDS, INC., is a consumer goods company specializing in brand development of health conscious, hemp-infused food and beverage products. The Company currently markets a lineup of four naturally flavored hemp-infused beverages (Citrus Energy, Black Tea, Mango Energy and Lemonade) and a low calorie Coconut Lime Energy drink. In the near future, the Company will introduce hemp-infused food products that include a protein bar, energy bar, and a chia crisp bar.  Rocky Mountain High Brands plans to offer hemp-infused 2oz. energy shots and 2.5oz. coffee shots to its product line.
For interested investors, our stock symbol is RMHB.
For ordering information please visit: www.RockyMountainHighBrands.com
For Rocky Mountain High Distribution Contact:
Chuck Smith (972) 955-0964
chuck@rockymountainhighbrands.com
Visit us on Twitter: #GetYourHempOn

Pepsi Sales Have Gone Flat


New Pepsi, Old Problem: U.S. Soda Sales Have Lost Their Fizz

Jennifer Kaplan
https://i1.wp.com/cdn.pophangover.com/wp-content/uploads/2012/12/girl-diet-pepsi.jpg
PepsiCo Inc.’s ($PEP) moves this week mask a harder truth for the soft-drink industry: Soda sales are down no matter how you sweeten it.
Pepsi said Monday it’s bringing back Diet Pepsi with aspartame. That came after the company replaced the drink with a sucralose version last August. In all, the company will be selling three Pepsi-branded diet drinks — one sweetened with sucralose, two with aspartame.
The U.S. Food and Drug Administration and the European Food Safety Authority say aspartame is safe, and the  American Cancer Society says worries about an increased cancer risk are unfounded. Nonetheless, rumors persist, and the consumer push for natural ingredients doesn’t help.
At the same time, sucralose simply didn’t taste good to many Diet Pepsi drinkers.
The churn was unavoidably reminiscent of Coca Cola Co.’s ($KO) 1980s flirtation with a new recipe , but with an important difference. It almost didn’t matter what Pepsi did with the formulations of its sugar-free products. Per-person soda consumption in the U.S. fell to a 30-year low last year, according to Beverage Digest. And the 2016 numbers don’t look any better.
“Everybody should’ve learned from the Coke Classic fiasco that if you make a change in your product formulation, you mustn’t tell anybody about it,” said Marion Nestle, a New York University nutrition professor and author of “Soda Politics: Taking on Big Soda (and Winning).”
Diet Pepsi’s sales volume fell 5.8 percent in 2015 and dropped roughly 11 percent at retail during the first quarter of 2016, according to data from Beverage Digest, which first reported the product changes. Sales of Diet Coke, which is sweetened with aspartame, fell 5.6 percent in 2015 and 5.7 percent at retail in the first quarter of 2016.
“The non-aspartame version was essentially a disaster for Diet Pepsi,” said Ali Dibadj, an analyst at Sanford C. Bernstein & Co. “They lost share, lost volume and may have lost some consumers for good. The return of aspartame is an attempt at getting back in the saddle in diets, but that will be tough to do.”
Sucralose-sweetened Diet Pepsi will remain the Purchase, New York-based company’s “primary diet cola offering.” It will be sold alongside aspartame-sweetened Diet Pepsi Classic Sweetener Blend, PepsiCo said Monday. And Pepsi Max — the No. 2 soft-drink maker’s answer to No. 1 Coca-Cola’s Coke Zero — will be called Pepsi Zero Sugar in the U.S. It also contains aspartame.
Pepsi and Coke are stuck between irreconcilable health concerns. With obesity such a big problem in the U.S., people are rejecting sugar-laden sodas. But the trend toward health doesn’t include diet drinks because pop consumers want natural products, not artificial sweeteners. And nature’s perfect zero-calorie sugar substitute — free of any unpleasant aftertaste — has yet to be invented.
When it comes to health — and particularly weight loss — diet drinks are better than the sugary kinds, said Yoni Freedhoff, a family doctor and obesity specialist.
Given the choice, however, Freedhoff said he would check “none of the above.”
“How much more awesome would it be if we could just avoid sweeteners and be healthy?” Freedhoff said. “That would be terrific.”

Marijuana To Be Made Legal On August 1st.


U.S. Gov’t Will Legalize Marijuana on August 1

Federal Preemption means weed will soon be legal in all 50 states, with a prescription

The U.S. Drug Enforcement Administration will reclassify marijuana as a “Schedule Two” drug on August 1, 2016, essentially legalizing medicinal cannabis in all 50 states with a doctor’s prescription, said a DEA lawyer with knowledge of the matter.

The DEA Lawyer had told the lawyer representing a DEA informant of the DEA’s plan to legalize medicinal cannabis nationwide on August 1, 2016. When questioned by our reporter, the DEA lawyer felt compelled to admit the truth to him as well.
“Whatever the law may be in California, Arizona or Utah or any other State, because of Federal preemption this will have the effect of making THC products legal with a prescription, in all 50 states,” the DEA attorney told the Observer. Federal Preemption is a legal doctrine that where the US Government regulates a particular field, State and local laws are overridden and of no effect.
He explained that “there are five DEA schedules. Nothing on Schedule One is ever legal, and that is where Cannabis is today. Schedule Two drugs are available with a prescription.”
On Schedule Two, marijuana will join drugs like Percocet, Xanax, Oxycontin, Abilify and other drugs that are legal, even common, with a prescription. There are also other drugs that are not on any schedules but that are illegal on a federal level, he said. Drugs like aspirin and ibuprofen are available over-the-counter.
He opined that the 135 medicinal cannabis clinic owners in Los Angeles will no doubt oppose this move by the Federal government, because the rule change will eliminate any reason for people to visit medical marijuana clinics. “In my opinion, CVS pharmacy, Rite-Aid and Walgreens will sell Schedule Two THC products similar to what users call “edibles,” but will not sell smokable weed because of the health risk smoking anything entails,” said the DEA lawyer. 
The Los Angeles based DEA Attorney who spoke to us, asked to remain anonymous because he was not authorized to speak to the press about the matter. He speculated that this action will be taken in the closing days of the 2016 U.S. Presidential election, so as to motivate the Democratic base to turn out and vote for Hillary Clinton, and other down ballot candidates. She will certainly not reverse this policy decision taken in the waning days of the Barack Obama administration, he said. But Donald Trump might.

“Marijuana enforcement is a big drain on DEA resources,” he said was another reason for the change, noting that a majority of the American public favor the legalization of marijuana for medical use.

Libertarian candidate Gary Johnson is in favor of legalizing marijuana and in fact owns a business which pedals pot in New Mexico.
California will vote on November 7th, 2016, whether to legalize the recreational use of marijuana. Because of Federal preemption, the DEA’s reclassification of cannabis as a Schedule Two drug, will have the legal effect of requiring a prescription in California–i.e., it will continue the status quo.
Since the Golden State legalized medical marijuana almost 20 years ago, Federal authorities have occasionally raided medical marijuana clinics here. They have forced major banks, like Bank of America, to close clinic bank accounts. The Feds have even seized real estate belonging to landlords who rent space to pot clinics. The Federal war on medicinal marijuana will abruptly end on August 1, 2016.
8/01 is the new 4/20!

Medical cannabis, or medical marijuana, can refer to the use of cannabis and its cannabinoids to treat disease or improve symptoms; However, there is no single agreed upon definition, says Wikipedia. The use of cannabis as a medicine has not been rigorously scientifically tested, often due to production restrictions and other governmental regulations. There is limited evidence suggesting cannabis can be used to reduce nausea and vomiting during chemotherapy, to improve appetite in people with HIV/AIDS, and to treat chronic pain and muscle spasms. Its use for other medical applications, however, is insufficient for conclusions about safety or efficacy.

In California, there are “weed doctors” who will write a prescription for cannabis to anyone claiming to suffer from anxiety, which means they passout prescriptions for pot like chocolate bars at a Halloween party. As with so many other trends that started in California, expect to see medicinal marijuana sold in your town soon!
Medical cannabis can be administered using a variety of methods, including liquid tinctures, vaporizing or smoking dried buds, eating cannabis edibles, taking capsules, using lozenges, dermal patches or oral/dermal sprays. Synthetic cannabinoids are available as prescription drugs in some countries; examples include: dronabinol and nabilone.
Recreational use of cannabis is illegal in most parts of the world, but the medical use of cannabis is legal in certain countries, including Austria, Australia, Canada, Czech Republic, Finland, Germany, Israel, Italy, the Netherlands (where it is also legal recreationally), Portugal and Spain.
In the United States, federal law outlaws all cannabis use, while 25 states and the District of Columbia no longer prosecute individuals for the possession or sale of medical marijuana, as long as the individuals are in compliance with the state’s medical marijuana sale regulations.
The DEA lawyer gave us his legal opinion that if you happen to live where recreational marijuana is now legal, i.e. Colorado or Washington State; after August 1, you will need a prescription, as you would need throughout the U.S.
However, an appeals court ruled in January 2014 that a 2007 Ninth Circuit ruling remains binding in relation to the ongoing illegality, in federal legislative terms, of Californian cannabis dispensaries, reaffirming the impact of the federal Controlled Substances Act.
The Federal Government will make Marijuana a Schedule Two drug on August 1, 2016, effectively legalizing weed throughout the US. You may be able to buy pot at Rite Aid in Santa Monica by the end of the year.
As explained above, moving marijuana from Schedule One to Schedule Two, would have the effect of legalizing medicinal marijuana, throughout all 50 States, the District of Columbia and U.S. territories. This action may be taken by the DEA unilaterally–i.e., without specific Congressional authorization — because Congress has previously granted the DEA rule-making authority over what drugs are on which schedules.
The Drug Enforcement Administration (DEA) is a United States federal law enforcement agency under the U.S. Department of Justice, tasked with combating drug smuggling and use within the United States. Not only is the DEA the lead agency for domestic enforcement of the Controlled Substances Act, sharing concurrent jurisdiction with the Federal Bureau of Investigation (FBI) and Immigration and Customs Enforcement (ICE), it also has sole responsibility for coordinating and pursuing U.S. drug investigations abroad.

Should Coke and Pepsi Be Worried About The New Soda Tax


New Philadelphia Soda Tax: Should Pepsi, Coca-Cola Worry?

Zacks Equity Research
Beverage biggies, The Coca-Cola Company KO and PepsiCo, Inc. PEP, will now have to bear an extra tax on its sodas in Philadelphia, one of the biggest cities in the U.S. to have approved a soda tax.
The Tax
The Philadelphia city council, on Thursday, finally approved a 1.5 cent-per-ounce tax on sugary drinks by a vote of 13-4. Sugary drinks include regular and diet soda and energy drinks. The tax is set to take effect next year.
The Purpose of the Tax
Mayor Jim Kenney’s proposed tax is not exactly an attempt to limit sugar consumption in the city.
The estimated $90 million in new tax revenue next year is proposed to be used to fund expansion of prekindergarten and community schools and an overhaul of recreation centers.
Only Berkeley, CA, imposes a similar tax on sugary drinks. Soda tax proposals have failed in many cities and states in recent years. The success tasted in Philadelphia will be a boost for other cities considering such a tax.
Burden for Pepsi & Coca-Cola
The soda tax is expected to reduce the consumption of sugary drinks in the city, which will hurt soda sales of companies like Coca-Cola, Pepsi and Dr Pepper Snapple Group, Inc. DPS.
As it is, cross-category competition and growing health and wellness consciousness have been hurting demand for carbonated beverages. Consumers have become vigilant about the high sugar content of these drinks and related obesity concerns. Diet drinks are also under pressure due to increasing consumer concern regarding the use of artificial sweeteners.
This has kept soda companies on their toes. The imposition of the soda tax comes as an added blow. The beverage industry ran an advertising campaign against the Philadelphia soda tax, arguing that the tax would be costly for consumers. The American Beverage Association, which also tried very hard to convince the council to vote against the soda tax, called it “discriminatory and highly unpopular.”

Sector Price Index

 

 

Sector Price Index
Is it a Lose-It-All Situation?
Not exactly. A similar tax of 10% on a liter was imposed on sugary drinks in Mexico more than two years back. Though this hurt sales of soda companies in the country for some quarters, they’ve started picking up in Mexico lately.
Moreover, with health concerns intensifying over the years, these bigwigs have been diversifying beyond their carbonated beverages into “healthier” categories like yoghurt, juices, water and dairy. While Coca-Cola is pursuing investments in newer revenue platforms to boost long-term sales and profits, Dr Pepper is forging distribution/partnership agreements with emerging, high-growth, third-party brands, which allow the company to participate in adjacent and growing beverage categories. Pepsi, on the other hand, has its hugely successful snacks business to bank upon.
Also, these companies are offering more package sizes to their customers, like smaller cans and bottles, so that they can limit their calories.
Moreover, these companies have been undertaking various productivity initiatives to streamline their cost structure, thereby boosting profits.
The extra tax in Philadelphia will undoubtedly hurt these companies’ profits in the near future. Nonetheless, in the long term, they should be able to come up with some plan – breakthrough innovations, aggressive cost cuts, re-structuring or strategic initiatives –  to make up for the lost dough.

Death Of The Your Local Shopping Mall


America’s Shopping Malls Are Dying A Slow, Ugly Death

 

 

The Canton Centre Mall in Canton, Ohio is boarded up and vacant.Nicholas Eckhart
 

All across America, once-vibrant shopping malls are boarded up and decaying.
Traffic-driving anchors like Sears and JCPenney are shutting down stores, and mall owners are having a hard time finding retailers large enough to replace them. With a fresh wave of closures on the horizon, the problem is set to accelerate, according to retail and real estate analysts.

 
About 15% of U.S. malls will fail or be converted into non-retail space within the next 10 years, according to Green Street Advisors, a real estate and REIT analytics firm. That’s an increase from less than two years ago, when the firm predicted 10% of malls would fail or be converted.
“The risk of failure for a mall increases dramatically once you see anchor closures,” said Cedric Lachance, managing director of Green Street Advisors. “Their health is very important … and most of them are highly likely to continue closing stores.”
Within 15 to 20 years, retail consultant Howard Davidowitz expects as many as half of America’s shopping malls to fail. He predicts that only upscale shopping centers with anchors like Saks Fifth Avenue and Neiman Marcus will survive.
“Middle-level stores in middle-level malls are going to be extinct because they don’t make sense,” said Davidowitz, chairman of Davidowitz & Associates, Inc., a retail consulting and investment banking firm. “That’s why we haven’t built a major enclosed mall since 2006.”

This building once housed a Macy’s, which closed in 2008 and has since remained untouched:

Dead MallNicholas Eckhart
Of the roughly 1,000 malls in the U.S., about 400 cater to upper-income shoppers, he said. For those higher-end malls, business is improving, according to data from Green Street Advisors. It’s the lower-end malls that are being hit by store closures.

JCPenney, Macy’s, and Sears have all recently announced fresh rounds of closures and layoffs. JCPenney is closing 33 stores, Macy’s is closing five, and Sears is closing its flagship in Chicago — the latest of about 300 closures Sears has made since 2010.

As those retailers vacate their hulking, multi-story spaces, mall owners are aiming to replace them with movie theaters, restaurants, and discount retailers like TJ Maxx, Ross Stores, and Marshalls, analysts said.

But if a mall is hit by two or more anchor closures at once, it’s harder to stay afloat. That’s typically the beginning of a downward spiral leading to ultimate extinction, Lachance said.

Most struggling malls don’t go down without a long, drawn-out fight, however — the evidence of which exists in hundreds of communities across the country where vacant wings of various shopping centers are beginning to crumble and decay. States hit particularly badly include Texas, Pennsylvania, Ohio, New York, and Illinois, according to Deadmalls.com, which tracks mall closures.

Here’s the interior of Rolling Acres Mall in Akron, Ohio, which has been closed since 2008: 

Dead mallNicholas Eckhart
“Malls will go broke, will go dark, will get closed — and it will take eight years for something to be redeveloped,” Davidowitz said.

Don Wood, the CEO of Federal Reality Investment Trust, has said the process of knocking down or converting a mall could take as long as two decades.
“It’s really going to be hard in the next 10 years to knock down that mall and rebuild it into something better because the economics just don’t work,” Wood said at a conference in June 2012, according to The Wall Street Journal. A failing mall in a non-affluent market “most likely will just stay there and get worse and worse over the next 20 years.”

What will eventually replace these ghost malls are community colleges, business offices, and health care facilities, according to Green Street Advisors.

Until then, many of these former shopping hubs will continue the gradual process of boarding up windows and turning out the lights, one store after another.

Rite Aid Shares Slip Even With Walgreens’ Likely Acquisition


Rite Aid shares slip as first-quarter earnings fall short

 

 

Pharmacy reimbursement rates challenged Rite Aid earnings in the latest quarter, Chairman and CEO John Standley said, in a statement.

Rite Aid shares slipped more than 1 percent Thursday after releasing its first-quarter results.
The drugstore chain reported adjusted quarterly earnings at 1 cent per share, below a Reuters estimate of 5 cents a share. Revenue rose 23 percent to $8.2 billion on a year-over-year basis, but came in below a forecast of $8.26 billion.

 

 

 
Standley said the chain wasn’t able to offset the rate pressure through drug purchasing efficiencies.

 
“While drug cost reductions will continue to be short of our expectations in the near term, we anticipate improvements over the second half of the fiscal year. As we work to meet this challenge, we remain focused on executing our highly successful sales initiatives like wellness+ with Plenti and the Wellness store program while also making strategic investments for growth and delivering a consistently outstanding customer experience,” he said in a statement.
Shares of Rite Aid jumped last week after a report said there are growing signs that the Federal Trade Commission will approve Walgreens’ $17 billion acquisition of Rite Aid. The two drugstores agreed to merge in February 2015.
 

 

Rite Aid said it expects to close deal with Walgreens Boots Alliance in the second half of this year.

 
Rite Aid’s stock has remained steady this year, dipping about 1 percent.

Soft Drink Industry Faces Continued Weakness


As Coke, Pepsi, Dr Pepper battle for beverage leverage, other options pour in

Each of the Big Three soft drink makers — Coke, Pepsi and Dr Pepper — has a significant presence in North Texas.

Plano is home to the Dr Pepper Snapple Group and PepsiCo’s snack division, Frito-Lay. Atlanta-based Coke has six facilities here, including distribution centers and a syrup plant.

The soft drink industry faces continued weakness in the sales of its main product — soda — due to concerns about calories, sugar and artificial sweeteners.

So each company is looking for other items, such as snacks and energy drinks, to bolster total sales.

BP Share Price Falls With Oil Prices


The United States rig counts increased for the second straight week, which sent oil prices in the opposite direction, Friday. And this combination, compounded by the strong dollar, weighed on shares of BP p.l.c. (BP), which declined Friday by as much as 2.78% to a session low of $32.12.

Energy Starting to Cool Off

The number of rigs operating in the U.S. fields rose to 328, compared to 325 from the previous week, according to Reuters, citing data compiled by oilfield services firm Baker Hughes Incorporated (BHI). Comparatively, this still marks a drastic decline of almost 50% from the same period a year ago when rig counts reached 635 rigs online. (See also: 3 Reasons Why U.S. Oil Imports Are Rising.)

The U.S. oil prices closed on Friday below $50 per barrel, an important psychological benchmark for the market. Crude oil (West Texas Intermediate) closed Friday at $48.88, down 2.95%, while Brent crude was unchanged, closing at $50.54, according to CNBC.com. But prices are still well off their year lows of around $25 per barrel reached in January.

The pullback in energy didn’t impede BP’s willingness to merge its Norwegian business with a subsidiary of Det Norske Oljeselskap ASA (DETNF). London-based BP said the $1.3 billion joint venture, called Aker BP, will be an all-stock deal that will help the combined company lower operating costs, Reuters reports. Aker will own 40% of the joint venture and will be the main shareholder, while BP will own 30%. Reuters noted that the remaining stake will be held by other shareholders. (See also: BP Strategizes Profits Amid Slumping Oil Prices.)

The Bottom Line

BP stock closed Friday at $32.22, down 2.48%. The shares have risen 3.07% year-to-date, while falling 21% over the past twelve months. This compares with a 2.55% year-to-date rise in the S&P 500 (SPX) index. BP stock has a consensus hold rating and an average analyst 12-month price target of $35.95, implying an 11.48% rise from current levels.

Rocky Mountain High Brands, Inc. (RMHB) To Be Featured Guest On “Your Monies Worth” Radio Show


Rocky Mountain High Brands, Inc. (RMHB) To Be Featured Guest On “Your Monies Worth” Radio Show

DALLAS, June 09, 2016 (GLOBE NEWSWIRE) —
Rocky Mountain High Brands, Inc. (OTC PINK:RMHB) announced today it will be LIVE in an on-air radio interview Friday, June 10th at 5:00 PM EDT on Radio 1470 AM WWNN and a web streamed simulcast at www.AMP2.TV.  Jerry Grisaffi, Founder of RMHB, will be interviewed by longtime radio host Mick Bazsuly of WWNN AM Miami-Fort Lauderdale.
Cynthia E. Ferguson, the Show’s Co-Host and Assistant Producer, said, “Your Monies Worth has been continuously aired for thirteen years and is centered on unique companies with huge potential. Rocky Mountain High Brands has recently reformulated the Mango Energy and introduced the new Low Calorie Coconut Lime Energy drink.  In addition, the Company has produced the first of several edible hemp-infused products, the new Relaxation Brownie.”
Mick Bazsuly commented, “We have been closely monitoring the growth of this amazing company. We are excited to get the opportunity to have Jerry Grisaffi back on the show and update the progress as the brand has gained popularity across the country.”
 Rocky Mountain High Brands is the exclusive energy drink sponsor of the Taste of Country Festival at Hunter Mountain this weekend (June 10-12) where thousands of thirsty fans will be in attendance to this multi-day event featuring Kenny Chesney, Jake Owen, Kid Rock, Gary Allen, Big and Rich and many more.
Visit Taste of Country Festival: http://tasteofcountryfestival.com/
Bazsuly continued, “This week’s radio show will also feature Cleartronic (CLRI), a software and communications developer in an interview with Mr. Larry Reid who will discuss recent growth in sales and expansion.”
Live call in at: (888) 565-1470
email questions direct at: mickespn@aol.com
The interview will be aired live worldwide on: http://www.wwnnradio.com/
World Wide Web Simulcast: https://www.amp2.tv/
About Rocky Mountain High Brands:
ROCKY MOUNTAIN HIGH BRANDS, INC., is a consumer goods company specializing in brand development of health conscious, hemp-infused food and beverage products. The Company currently markets a lineup of four naturally flavored hemp-infused beverages (Citrus Energy, Black Tea, Mango Energy and Lemonade) and a low calorie Coconut Lime Energy drink. In the near future, the Company will introduce hemp-infused food products that include a protein bar, an energy bar, and a chia crisp bar.  Rocky Mountain High Brands plans to offer hemp-infused 2oz. energy shots and 2.5oz. Coffee shots to its product line.
Interested investors, our stock symbol is RMHB.
For ordering information please visit: www.RockyMountainHighBrands.com
For Rocky Mountain High Distribution Contact:
Chuck Smith: (972) 955-0964
chuck@rockymountainhighbrands.com
Visit us on Twitter: #GetYourHempOn https://twitter.com/search?q=%23getyourhempon&src=typd
Investors Hangout is the only authorized Investors blog page for Rocky Mountain High Brands, Inc.

Frozen KOLD Machine Was Meant To Be KEURIG’s Future


Keurig is axing the machine that was meant to be the future of the brand

Kate Taylor
 Keurig is shutting down the machine that the brand had hoped could build a future beyond coffee.
On Tuesday, Keurig Green Mountain announced it is discontinuing the Keurig Kold system.
Consumers who already purchased a Keurig Kold — a $370 machine that creates carbonated, chilled beverages — can get a full refund from the company. Keurig will continue to sell pods until supplies run out.
“We view our initial Kold system launch as a pioneering execution,” Keurig said in a statement. “We learned a lot — including that consumers are willing to embrace the concept of a system that delivers fresh-made, cold beverages in the home — and we’ll build our learnings into future beverage systems.”
The Keurig Kold debuted in September 2015, with Keurig staking its hopes on the new device crafting a future for the brand outside of coffee. However, almost immediately, customers began complaining about its size, noisiness, how long it took to make drinks, and the expensive $370 price tag.

Keurig had invested a lot of technology — and money — in the Keurig Kold. The company filed more than 50 patents over the course of five years as it developed the system, investing $100 billion in the device in fiscal 2015. In September, Keurig said it planned to spend a similar amount in 2016.
Keurig wasn’t the only company betting on the success of the Keurig Kold.
Coca-Cola spent $2.4 billion on a 16% stake in Keurig in 2014, and partnered with Keurig in creating Keurig Kold flavors, such as Diet Coke and Sprite. In December 2015, Keurig announced it was being acquired by JAB Group for $92 a share — valuing Keurig at $13.9 billion. (Coca-Cola sold its equity stake in the venture when it was acquired by JAB.)
For a while, it looked as though Keurig would persevere through the negative reviews of the product.

 

 

“We know that the first product we put out in the new technology is never going to be perfect,” Keurig CEO Brian Kelley said of the Kold in the company’s fourth quarter earnings call in November. “We’re going to learn and we’re going to improve.”
However, it’s unclear if Keurig will continue to pursue its goal of creating the cold beverage maker of the future.
With the discontinuation of the Keurig Kold, 108 Vermont employees lost their jobs, primarily from the Kold pod manufacturing and related support teams. Keurig said the ex-employees are encouraged to apply for one of the roughly 200 positions currently open at the company.
“Reimagining how beverages can be created, personalized and enjoyed will continue to guide Keurig’s strategy into the future,” a Keurig spokesperson said in a statement.